首页 | 本学科首页   官方微博 | 高级检索  
     

全身化疗联合经肝动脉化疗栓塞术治疗乳腺癌肝转移的疗效观察
引用本文:李立业. 全身化疗联合经肝动脉化疗栓塞术治疗乳腺癌肝转移的疗效观察[J]. 临床肝胆病杂志, 2016, 0(1): 97-100. DOI: 10.3969/j.issn.1001-5256.2016.01.017
作者姓名:李立业
作者单位:山东省医学科学院附属医院 外一科,济南,250031
摘    要:目的探讨发生肝转移的乳腺癌患者采用全身化疗联合经肝动脉化疗栓塞术(TACE)治疗的效果。方法选取2012年12月-2014年12月于山东省医学科学院附属医院接受治疗的乳腺癌并发肝转移女性患者86例,将其平均分为试验组和对照组。对照组采用全身化疗,试验组给予全身化疗基础上联合TACE治疗,比较2组临床疗效、病灶变化情况以及治疗后患者生活质量评分情况。计量资料组间比较采用t检验,计数资料组间比较采用χ2检验。结果试验组患者治疗的总有效率高于对照组,差异有统计学意义(90.70%vs 58.14%,χ2=13.07,P=0.001);与对照组相比,试验组患者治疗后肿瘤直径、淋巴结直径较小,差异均有统计学意义(t值分别为4.26、4.63,P值均0.001);试验组患者治疗后3、6个月生活质量评分均高于对照组,差异均有统计学意义(t值分别为6.30、3.89,P值均0.001)。结论对乳腺癌肝转移患者采用全身化疗联合TACE治疗的效果显著,能够改善患者症状,减少药物不良反应,提高生活质量,且安全可靠,值得推广应用。

关 键 词:乳腺肿瘤  肿瘤转移  药物疗法  化学栓塞,治疗性

Clinical effect of systemic chemotherapy combined with transcatheter arterial chemoembolization in treatment of breast cancer with liver metastases
Abstract:Objective Toinvestigatetheclinicaleffectofsystemicchemotherapycombinedwithtranscatheterarterialchemoembolization (TACE)inthetreatmentofbreastcancerwithlivermetastases.Methods Atotalof86femalebreastcancerpatientswithlivermetastases who were treated in the Affiliated Hospital of Shandong Academy of Medical Sciences from December 2012 to December 2014 were selected and equally divided into experimental group and control group.The patients in the control group received systemic chemotherapy,and those in the experimental group received systemic chemotherapy combined with TACE.The clinical effect,changes in lesions,and patients′quali-ty of life (QOL)scores after treatment were compared between two groups.The t-test was applied for comparison of continuous data be-tweenthetwogroups,andthechi-squaretestwasappliedforcomparisonofcategoricaldatabetweenthetwogroups.Results Theexperi-mental group had a significantly higher overall response rate than the control group (90.70%vs 58.14%,χ2 =13.07,P=0.001).Com-pared with the control group,the experimental group had significantly smaller diameters of tumors and lymph nodes after treatment (t=4.26 and 4.63,both P<0.001),as well as significantly higher QOL scores at 3 and 6 months after treatment (t=6.30 and 3.89,both P<0.001).Conclusion SystemicchemotherapycombinedwithTACEhasasignificanttherapeuticeffectinbreastcancerpatientswithliver metastases,and can improve patients′symptoms,reduce adverse drug reactions,and improve QOL.As a safe and reliable therapeutic meth-od,it is worthy of clinical application.
Keywords:breast neoplasms  neoplasm metastasis  drug therapy  chemoembolization,therapeutic
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号